New anti-leishmanial agents designed through molecular hybridization approach.
7d showed potent anti-leishmanial activity against both L. infantum & L. donovani.
7d EC 50 against L. infantum promastigotes, axenic amastigotes 1.59 & 1.4 µM.
7d EC 50 against L. donovani promastigotes, axenic & intracellular amastigotes 0.91 & 0.91 & 1.4 µM.
A series of piperazinyl-β-carboline-3-carboxamide derivatives were designed through a molecular hybridization approach. Designed analogues were synthesized, characterized and evaluated for anti-leishmanial activity against Leishmania infantum and Leishmania donovani. In L. infantum inhibition assay , compounds 7d, 7g and 7c displayed potent inhibition of promastigotes (EC 50 1.59, 1.47 and 3.73 µM respectively) and amastigotes (EC 50 1.4, 1.9 and 2.6 µM respectively). SAR studies revealed that, para substitution of methoxy, chloro groups and methyl group on ortho position favored anti-leishmanial activity against L. infantum. Among these analogues 7d, 7h, 7n and 7g exhibited potent inhibition against L. donovani promastigotes (EC 50 0.91, 4.0, 4.57 and 5.02 µM respectively), axenic amastigotes (EC 50 0.9, 3.5, 2.2 and 3.8 µM respectively) and intracellular amastigotes (EC 50 1.3, 7.8, 5.6 and 6.3 µM respectively). SAR studies suggested that, para substitution of methoxy group, para and meta substitution of chloro groups and benzyl replacement recommended for significant anti-leishmanial against L. donovani.